Delisting, Listing Rule Failure, or Listing Transfer

Vivakor, Inc. (VIVK) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K, dated December 19, 2025, addresses critical listing status issues for Vivakor, Inc., a Nevada corporation. The Company's common stock (VIVK) is registered on The Nasdaq Capital Market. The report details the Company's failure to meet Nasdaq listing standards, resulting in an imminent delisting and trading suspension.

Key Financial Metrics

The filing does not provide specific financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point disclosed is the stock price performance triggering the delisting:

  • Stock Price: The closing bid price was $0.10 or less for ten consecutive trading days as of December 19, 2025.
  • Minimum Bid Price Requirement: The Company failed to maintain the required $1.00 per share minimum bid price.

Material Changes and Delisting Events

The Company has received notification of delisting from The Nasdaq Stock Market LLC based on two primary deficiencies:

  • Low Priced Stocks Rule (Rule 5810(c)(3)(A)(iii)): After failing to regain compliance with the Minimum Bid Price Requirement during a Second Grace Period (ending March 16, 2026), the Company was deemed ineligible for further grace periods due to the stock trading at $0.10 or less for ten consecutive days.
  • Shareholder Approval Deficiency (Rule 5635(d)): The Company failed to obtain required shareholder approval for a transaction involving the issuance of 20% or more of pre-transaction shares at less than the Minimum Price.
  • Trading Suspension: Trading of the Common Stock was suspended at the opening of business on December 26, 2025.
  • Form 25-NSE: A Form 25-NSE will be filed to remove the Company's securities from listing and registration on Nasdaq.

Outlook, Management Commentary, and Risks

Management has initiated an appeal process regarding the delisting determination:

  • Appeal Status: An appeal was submitted on December 24, 2025.
  • Hearing Schedule: A hearing is scheduled for January 29, 2026, where the Company will present a plan to regain compliance.
  • Uncertainty: The Company explicitly states there can be no assurance that the appeal will be successful or that compliance with listing standards will be regained.
  • Compliance Plan: The Company is in the process of preparing a plan to address the deficiencies for the Hearings Panel.

Investor Verification Checklist

  • Verify the status of the appeal hearing scheduled for January 29, 2026.
  • Confirm the filing of Form 25-NSE and the official removal of VIVK from Nasdaq.
  • Monitor for any alternative trading venues (e.g., OTC markets) where the stock may trade post-delisting.
  • Review the specific transaction that triggered the shareholder approval deficiency under Rule 5635(d).
  • Assess the Company's liquidity and ability to fund operations given the suspension of trading and delisting status.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.